Company news
Transmedics Group, Inc. (NASDAQ:TMDX) news
Transmedics Group, Inc. news releases on 6ix. Latest, Jun 10, 2021: TransMedics Announces Scheduling of OCS Liver FDA Advisory Committee Meeting
Press releases — page 3
TransMedics Announces Scheduling of OCS Liver FDA Advisory Committee Meeting
June 9, 2021
TransMedics Announces Presentation of OCS Liver PROTECT Trial Results and is Recognized as Winner of The People's Choice Award for Most Impactful Presentation at the American Transplant Congress (ATC 2021)
June 7, 2021
TransMedics Reports First Quarter 2021 Financial Results
May 3, 2021
TransMedics to Report First Quarter 2021 Financial Results on May 4, 2021
April 19, 2021
TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Heart System
April 5, 2021
TransMedics Announces Positive FDA Advisory Committee Vote for OCS Heart System
April 5, 2021
TransMedics Appoints Stephanie Lovell to Board of Directors
March 23, 2021
TransMedics Reports Fourth Quarter and Full Year 2020 Financial Results
March 1, 2021
TransMedics Announces Scheduling of OCS Heart FDA Advisory Committee Meeting
February 28, 2021
TransMedics to Report Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021
February 15, 2021
TransMedics to Present at the Cowen 41st Annual Healthcare Conference
February 15, 2021
TransMedics to Present at the 39th Annual J.P. Morgan Healthcare Conference
December 23, 2020
TransMedics Appoints Merilee Raines to Board of Directors
December 22, 2020
TransMedics Reports Third Quarter 2020 Financial Results
November 3, 2020
TransMedics to Participate in Upcoming Virtual Investor Conferences
October 28, 2020
TransMedics to Report Third Quarter 2020 Financial Results on November 4, 2020
October 20, 2020
TransMedics Announces Temporary Postponement of OCS Heart FDA Advisory Panel Committee Meeting
September 27, 2020
TransMedics to Present at the 18th Annual Morgan Stanley Global Healthcare Conference
August 31, 2020
TransMedics Reports Second Quarter 2020 Financial Results
August 4, 2020
TransMedics to Present at the Canaccord 40th Annual Growth Conference
July 27, 2020
TransMedics to Report Second Quarter 2020 Financial Results on August 5, 2020
July 22, 2020
TransMedics Announces Pricing of Public Offering of Common Stock
May 25, 2020
TransMedics Announces Positive Top-line Results from U.S. Pivotal OCS™ Liver PROTECT Trial
May 25, 2020
TransMedics Reports First Quarter 2020 Financial Results
May 5, 2020
TransMedics to Report First Quarter 2020 Financial Results on May 6, 2020
April 22, 2020
TransMedics Provides COVID-19 Pandemic Update and Announces Preliminary Financial Results for First Quarter 2020
April 12, 2020
TransMedics Announces Temporary Postponement of OCS Heart FDA Advisory Panel Committee Meeting Due to COVID-19 Emergency
March 16, 2020
TransMedics Reports Fourth Quarter and Full Year 2019 Financial Results
March 1, 2020
TransMedics to Present at the Cowen 40th Annual Health Care Conference
February 19, 2020
TransMedics to Report Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020
February 18, 2020
TransMedics to Present at the 38th Annual J.P. Morgan Healthcare Conference
December 18, 2019
TransMedics’ Organ Care System (OCS™) Technology Used in First U.S. Adult Human Heart Transplants From DCD Donors
December 3, 2019
TransMedics Reports Third Quarter 2019 Financial Results
November 5, 2019
TransMedics Announces Change to Time of Third Quarter 2019 Earnings Conference Call on Wednesday, November 6
October 22, 2019
TransMedics to Report Third Quarter 2019 Financial Results on November 6, 2019
October 15, 2019